Autres langues DexCom, Inc.

Actions

DXCM

US2521311074

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/06/2026			Varia. 5j.	Varia. 1 janv.
70,14 ^USD	+2,17%		-3,22%	+5,68%

23/06	DEXCOM, INC. : Opinion positive de Deutsche Bank Securities	ZM
16/06	L'intelligence artificielle peut jouer un rôle " significatif » dans les technologies de gestion du diabète, selon David Roman	MT

Autres langues

23/06	Dexcom Further Advances Vision of Glucose Biosensing for All
16/06	AI Can Play 'Significant' Role in Tech for Managing Diabetes, Says David Roman
13/06	Dexcom Inc Clears First Over-The-Counter Continuous Glucose Monitor For Children
12/06	FDA clears first over-the-counter glucose monitor for children
11/06	Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction
10/06	Compañías que se deben tener muy en cuenta por técnico este miércoles en Wall Street
10/06	Analyst recommendations: Nike, Pfizer, Hewlett Packard, Intel, The Trade Desk…
10/06	Valores destacados al cierre del mercado norteamericano
06/06	Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
06/06	Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study
06/06	DexCom, Inc. Announces Results From CONNECT Randomized Controlled Trial Demonstrating Use Of Dexcom G7 Leads To Clinically And Statistically Significant Reduction In A1C And Improvement In Glucose Control Among People With Type 2 Diabetes Not Using Insulin
04/06	Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026
04/06	DexCom Presents Results from The CONNECT Randomized Control Trial, Launches Reimagined Stelo Ap
02/06	Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience
29/05	Compañías que se deben tener muy en cuenta por técnico este viernes en Wall Street
29/05	Valores destacados al cierre del mercado norteamericano
27/05	Signos, Inc announced that it has received $20 million in funding from GV Management Company, LLC, DexCom, Inc., Blue Cross and Blue Shield of Alabama
27/05	Signos raises $20 million investment from Google Ventures, Dexcom, Blue Cross Blue Shield of Alabama
26/05	Dexcom warns patients as stolen glucose sensors hit the market
26/05	DexCom Reports Theft of Scrapped G7 Glucose Monitor Sensors
26/05	Dexcom uncovers theft of scrapped product, notifies potentially impacted users
26/05	Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users
23/05	Dexcom Inc Announces Product Recall
23/05	Dexcom Inc Announces Product Recall
23/05	Dexcom Inc Announces Product Recall